Healthcare
Tampa Bay Teen Named 2026 National Teen of Impact Winner for Heart Health Advocacy
Leonardo Oliveira, a Tampa Bay teen, was named the 2026 American Heart Association National Teen of Impact Winner for raising awareness and funds for nutrition and heart health, highlighting the importance of early cardiovascular disease prevention.
LogicMark's Aster App Aims to Replace Informal Safety Habits with Structured Protection for Women
LogicMark's Aster app turns smartphones into personal safety devices, addressing the shortcomings of informal methods like texting friends or sharing location, and offering round-the-clock structured emergency support.
Wearable Wristband Shows Promise in Detecting Cardiac Arrest, Study Finds
New research published in Circulation: Arrhythmia and Electrophysiology demonstrates that a smart wristband using photoplethysmography can detect cardiac arrest with 92% accuracy in a clinical setting, potentially enabling faster emergency response and improved survival for out-of-hospital cardiac arrest.
Heat Waves and Nutrient Depletion: ORGANA International Highlights the Role of Plant-Derived Minerals in Summer Hydration
As temperatures rise, ORGANA International warns that summer heat can accelerate mineral loss through perspiration, emphasizing the importance of plant-derived fulvic minerals for hydration and energy balance.
Viromed Medical AG Partners with NEBU-TEC to Distribute PulmoPlas for Veterinary Use, Targeting Equine Respiratory Diseases
Viromed Medical AG has signed an exclusive global distribution partnership with NEBU-TEC to combine its cold plasma technology with nebulization for veterinary applications, initially focusing on respiratory diseases in horses, with a market launch planned for later in 2026.
Cardio Diagnostics Advances Personalized Heart Care Through AI and Epigenetics
Cardio Diagnostics Holdings is leveraging AI, epigenetics, and genetic insights to shift cardiovascular care from reactive treatment to predictive prevention, addressing heart disease as the leading cause of death worldwide.
GeoVax Highlights Need for Domestic MVA Vaccine Infrastructure Amid Global Outbreaks
As WHO declares Ebola a public health emergency and mpox spreads, GeoVax emphasizes the strategic importance of scalable U.S.-based MVA manufacturing for biodefense.
GeoVax Raises $3 Million in Private Placement to Fund Vaccine Development
GeoVax Labs secures $3 million through a private placement with institutional investors to advance its mpox/smallpox vaccine and other pipeline programs.
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit to Accelerate AI-Driven Antibody Discovery
Sino Biological's new XPressMAX™ Cell-Free Protein Synthesis Kit enables ultra-fast protein synthesis in three hours, supporting AI-powered high-throughput antibody drug discovery by eliminating traditional cell-based constraints.
Oragenics Advances Phase IIa Concussion Trial, Eyes CNS Device Licensing
Oragenics provided a shareholder update on its Phase IIa trial of ONP-002 for concussion in Australia, plans for U.S. regulatory meetings, and a letter of intent to license a complementary CNS medical device.
NanoViricides Highlights Broad-Spectrum Antiviral NV-387 Amid Ebola Outbreak
NanoViricides underscores the potential of its oral drug candidate NV-387 as a pandemic preparedness tool amid the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo and Uganda.
Quantum BioPharma Reaches Midpoint Enrollment in MS Imaging Study, Showing Encouraging Early Data
Quantum BioPharma announced that patient enrollment in its multiple sclerosis imaging study with Massachusetts General Hospital has reached 50%, with preliminary PET imaging data showing promising signals in acute MS lesions and potential sensitivity to gray matter lesions, which could accelerate development of MS therapies including its candidate Lucid-MS.
Lantern Pharma Reports Q1 2026 Results: 47% R&D Cost Reduction and AI Platform Commercialization
Lantern Pharma's Q1 2026 results show a 47% year-over-year reduction in R&D spending, successful FDA milestones, and the launch of withZeta.ai, a commercial AI drug development platform that opens a new revenue stream and extends cash runway into 2027.
What Sets the Best Orthodontist Apart: A Comprehensive Checklist for Hudson Valley Families
A new guide highlights key qualities like board certification, advanced technology, and emergency care that define top orthodontic practices in the Hudson Valley, with Van Vliet & Ganz Orthodontics cited as a model provider.
Fairhope Pediatric Dentist Launches Free Consultations to Boost Early Dental Visits
Fairhope Children's Dentistry introduces free consultations for new pediatric patients to reduce barriers to early dental care, emphasizing preventive strategies that improve long-term oral health outcomes in children.
San Elijo Pediatric Dentistry & Orthodontics Expands Integrated Care Model in San Marcos
San Elijo Pediatric Dentistry & Orthodontics has expanded its integrated pediatric dental and orthodontic services in San Marcos, California, offering families a single destination for comprehensive children's oral health care and oral conscious sedation to address dental anxiety.
Bonita Springs Gains Non-Surgical Contouring Specialist with 9 Years of Experience
Kristi, an experienced aesthetician and body contouring specialist, joins Anne Therese Aesthetic Medicine in Bonita Springs, offering personalized non-surgical body sculpting and facials to enhance natural body lines and boost client confidence.
American Heart Association Launches Initiative to Close Technology Gaps in Emergency Cardiac and Stroke Care
The American Heart Association, with support from T-Mobile, is launching an initiative to identify and close technology and communication gaps in emergency response for cardiac arrest, heart attack, and stroke across 13 U.S. cities.
Global Collaboration Urged to Reduce Heart Risks in Children with Kawasaki Disease
A new science advisory from the American Heart Association emphasizes that international collaboration in research, diagnosis, and care is essential to reduce the risk of serious heart conditions in children with Kawasaki disease worldwide.
Feldman Orthodontics Tailors Invisalign for Working Professionals in Wallingford
Feldman Orthodontics expands adult Invisalign services to meet the needs of working professionals who prioritize discretion and scheduling flexibility over traditional braces.
San Diego Dental Practice Expands Invisalign and Implant Services Under Dr. Raymond Wright III
Radiant Smiles in San Diego broadens its restorative and cosmetic offerings, including dental implants and Invisalign, to meet patient demand for comprehensive care under one roof.
Door Services Corporation Expands Safety Offerings with New Horton Automatic Door Systems
Door Services Corporation introduces the upgraded Horton HD Storm™ sliding door system for high-wind environments and the groundbreaking Horton Behavioral Health Profiler® ICU, a first-of-its-kind solution for healthcare safety.
Wastewater Monitoring Could Offer Early Warning for Influenza Outbreaks, Japanese Study Suggests
A new study indicates that wastewater surveillance can predict influenza outbreaks up to a week earlier than patient data, aiding resource planning and public health responses, especially in underserved areas.
Cardio Diagnostics Leverages AI to Address Preventable Cardiovascular Disease
Cardio Diagnostics Holdings Inc. offers AI-powered solutions for early detection and prevention of cardiovascular disease, addressing the urgent need for more effective risk identification tools.
Vycor Medical Posts Operating Profit in Q1 2026 as International Sales Drive Revenue Growth
Vycor Medical reported a 5% revenue increase to $458,540 for Q1 2026, achieving an operating profit of $45,808 compared to a loss last year, driven by international expansion and supported by new clinical studies on its ViewSite Brain Access System.
Cardio Diagnostics Merges Precision Medicine and AI to Tackle Global Cardiovascular Disease Burden
Cardio Diagnostics Holdings (NASDAQ: CDIO) is leveraging artificial intelligence and epigenetic biomarkers to deliver personalized cardiovascular risk assessments from a simple blood test, positioning itself at the forefront of precision medicine and preventive care.
SureNano Science's GEP-44 Could Disrupt the Obesity Drug Market with Improved Tolerability
SureNano Science Ltd. is advancing GEP-44, a next-generation GLP-1 therapy with a triple agonist mechanism, aiming to improve upon current obesity treatments by offering better tolerability and potential non-injectable delivery.
NanoViricides Raises $2 Million in Registered Direct Offering to Advance Broad-Spectrum Antiviral Drug
NanoViricides announced a $2 million registered direct offering with a single institutional investor, aiming to fund development of its broad-spectrum antiviral NV-387, which targets multiple viruses including COVID-19, influenza, and RSV.
Oncotelic Therapeutics Reports Q1 2026 Results, Highlights Progress in Oncology and AI Drug Development
Oncotelic Therapeutics reported first-quarter 2026 financial results and a corporate update, emphasizing advances in its oncology pipeline, AI-enabled drug development platform, and nose-to-brain CNS delivery system, while maintaining a $388 million valuation of its stake in GMP Biotechnology.
Oncotelic Therapeutics Highlights CNS Drug Delivery Innovation in NetworkNewsAudio Editorial
Oncotelic Therapeutics was featured in a NetworkNewsAudio editorial discussing the challenges of the blood-brain barrier and the company's N2B delivery system, with implications for biodefense and Alzheimer's treatment.